The Cannigma

AUGUST 5, 2022

When antidepressants were first introduced in the mid-20 th century, they were a breakthrough in pharmaceuticals. Of the people who take antidepressants, 30% won’t respond to treatment. But what other options do people suffering from depression, particularly treatment-resistant depression, have? What is ketamine treatment?

Treatment 138

Treatment Research and Development Therapy Digestion 138

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. We know medical marijuana can be an effective and safe treatment for veterans and it is time to stop making them seek private, out-of-network physicians to access it.

Access 248

Access Marijuana Treatment Legislation 248

NORML

JULY 1, 2019

Three new laws intended to expand patient access to and the therapeutic value of Virginia’s medical cannabis program take effect July 1, 2019. “These bills help ensure that all patients are able to obtain and use the necessary therapeutic doses of their cannabis medicines regardless of location or physical ability.”

Law 268

Law Patients Access Oil 268

Cannabis Law Report

SEPTEMBER 2, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. In Europe, there is a clear trend towards the use of more precise formulations of unapproved cannabis products as well as pharmaceutical products.

Pharmaceutical 105

Pharmaceutical Clinical Trials Research and Development Cannabinoids 105

LifeCannMD

MARCH 31, 2025

At LifeCannMD, under the expert guidance of Dr. Fernando Fandino-Sende – Miami’s Top Cannabis Doctor, we understand that seeking medical cannabis treatment is more than a clinical decisionit’s a deeply personal journey toward wellness, often undertaken after considerable reflection and other failed interventions.

Treatment 80

Treatment Chronic Pain History Conditions 80

Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions.

Medicine 306

Medicine Research and Development Pharmaceutical Cannabis 306

FloridaMarijuana.net

JUNE 22, 2018

Patients who suffer from this condition also face other symptoms that are painful, inconvenient -to say the least, -and lower their quality of life. An article published on the marijuanadoctor.com website discusses the best strains of marijuana for patients with IBS.

Hybrid 189

Hybrid Marijuana Sativa Nerve Pain 189

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 Unlike “pharmaceutical CBD”—which contains zero traces of the psychoactive compound THC (tetrahydrocannabinol) and has been FDA-approved to treat Dravet syndrome and Lennox-Gastaut syndrome —artisanal CBD is non-mechanized and usually contains variable amounts of CBD and THC.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

FloridaMarijuana.net

AUGUST 16, 2018

Dementia cannot be confirmed until a patient is deceased. Dementia is hard on the patient, and often harder on the family or caregivers. The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. It is caused by physical changes in the brain.

Clinical Trials 184

Clinical Trials Marijuana Patients Pharmaceutical 184

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. Pennsylvania-based Groff North America is one of the companies that is getting a green light to experiment with the plant. territories.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Veriheal

APRIL 7, 2022

Now, a new study has found that medical marijuana (MMJ) shows promise as a treatment for MS. . As with many other conditions, there is a lack of research regarding the use of MMJ as an alternative treatment to relieve symptoms of MS. . The Need for Better MS Treatment. The Need for Better MS Treatment.

Patients 98

Patients Treatment Cannabinoids Pharmaceutical 98

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method. CBD for Mental Health Treatment.

Treatment 122

Treatment Research and Development CBD THC 122

FloridaMarijuana.net

JUNE 27, 2018

Psychiatrists readily prescribe pharmaceuticals over marijuana when a patient is diagnosed with clinical depression. Marijuana has also been linked to triggering other mental health conditions, such as schizophrenia, in patients that are at a high risk of psychosis; a mental disorder characterized by “detachment from reality.”

Treatment 100

Treatment Marijuana Data Conditions 100

Puff Puff Post

SEPTEMBER 25, 2019

Researchers across North America have been conducting studies on the effectiveness of Multiple Sclerosis treatment through cannabis. Currently, there is no cure for MS , and people are seeking alternative methods outside of standard pharmaceuticals and physical therapy to help treat their various symptoms. million in 2008 to 2.3

Treatment 100

Treatment Research and Development Pharmaceutical Therapy 100

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. Eligible patients registered with the state’s Department of Public Health can purchase cannabis oil from Georgia’s independent pharmacies.

Oil 98

Oil Patients Access THC 98

Veriheal

AUGUST 31, 2020

Most of the conventional methods for treating migraines involve pharmaceutical medication, which has been known to be accompanied by unwanted side effects, especially from opioid based medication. If you have ever suffered through a migraine , you’ll know how much an effective alleviator is necessary. What Does the Study Have to Say?

Treatment 98

Treatment Consumption Indica Hybrid 98

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain CBD Research and Development 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

MAY 31, 2023

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Patients 52

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 83

Pharmaceutical Clinical Trials Therapy Programs 83

FloridaMarijuana.net

AUGUST 15, 2018

Most commonly, patients report that tingling and numbness occur, usually in the hands and feet. More than ever, cannabis can aid in the treatment of chronic disease and as a supplement to other medical interventions and treatments. Neuropathy, or nerve damage, effects over 30 million Americans.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

CannaTech

JANUARY 16, 2019

Thanks to the recent emergence of regulated medical cannabis markets, the success of this versatile plant can be followed from farm to pharma and prescriber to patient, however, the origins of cannabis as medicine cannot be as simply traced as the plant is today from seed to sale. Of course, patients need product and product costs money.

Access 89

Access Patients Pharmaceutical Education 89

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. InMed has conducted preclinical pharmacology studies that suggest CBN in INM-755 may help relieve hallmark EB symptoms, including inflammation and pain, as well potentially restore the integrity of the skin in a subset of EB Simplex patients.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Project CBD

SEPTEMBER 12, 2023

Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. He would undergo a dozen surgeries and consume a steady diet of prescription narcotics and other pharmaceuticals.

Chronic Pain 233

Chronic Pain Treatment Cannabinoids Research and Development 233

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. It would not allow patients to smoke herbal marijuana or vape, but would allow forms including pills, oils, lozenges and patches.

Legislation 255

Legislation Patients Decriminalization Access 255

Cannabis Law Report

JULY 1, 2021

As Curaleaf International ‘s subsidiary Adven GmbH seeks to advance its medical cannabis products in Germany, it has teamed up with an Italian pharmaceutical company, Zambon Spa , with whom it will provide medical cannabis treatments for patients, with an initial focus on neurological therapies.

Treatment 71

Treatment Pharmaceutical Therapy Oil 71

Veriheal

SEPTEMBER 7, 2022

law—specifically, the Legalization of Marijuana for Medical Treatment Initiative of 1999—for a total of 225 days. ’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C.

Patients 98

Patients Programs Access Treatment 98

Veriheal

FEBRUARY 11, 2021

The objective of the survey published in December 2020 explored “ the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites ”. They conducted an online survey of patients from three medical practice sites.

Chronic Pain 93

Chronic Pain Patients Clinical Trials Treatment 93

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

Sensi Seeds

NOVEMBER 4, 2021

Sativex by GW Pharmaceuticals is the first fully approved cannabis-based medicine. It is an oral spray containing THC and CBD, used in the treatment of multiple sclerosis (MS) patients. Today, Sativex is available in at least 25 countries, including Canada and many EU countries.

Medicine 115

Medicine Pharmaceutical Treatment THC 115

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. RADNOR, Pa.–(BUSINESS

Pharmaceutical 76

Pharmaceutical Clinical Trials Treatment Patients 76

Veriheal

OCTOBER 13, 2020

Elevated levels of stress can even land these individuals in more discomfort, with IBD patients risking hospitalization due to inflammation. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? What is IBS? What is the Difference Between IBD and IBS?

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JUNE 10, 2021

–(BUSINESS WIRE)– CURE Pharmaceutical Holding Corp. We’ve been working to develop safe, accurately-dosed cannabis solutions for several years now and we believe that this collaboration will help us take that initiative to the next level and expand our reach,” said Rob Davidson, CURE Pharmaceutical CEO. OXNARD, Calif.–(BUSINESS

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

Cannabis Law Report

JUNE 23, 2021

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S).

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

Greencamp

MAY 1, 2019

Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. Cannabis is now commonly used for treating chronic nausea, vomiting caused by chemotherapy and severe nausea caused by HIV and AIDS treatments.

Patients 89

Patients Strains Sativa Marijuana 89

NewsMunchies

JULY 10, 2023

AI tools are gaining popularity in biomedical research because while it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, using AI could vastly accelerate the drug-development process. AI automation opens up the possibility of faster, cheaper pharmaceuticals.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58